Spinal Muscular Atrophy Market

Spinal Muscular Atrophy Market - Pipeline Assessment, Size, Growth, Trends, and Forecast 2015 - 2023

  • Rep Id : TMRGL7187
  • Published On : Oct 2015
  • No. of Pages : 44
  • Category : Pharmaceutical

Chapter 1 Introduction 
1.1 Report Description 
1.2 Research Methodology 
1.3 Market Segmentation
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Pipeline Analysis: Spinal Muscular Atrophy- Market Snapshot

Chapter 3 Pipeline Analysis: Spinal Muscular Atrophy Market Overview 
3.1 Market Definition and Overview
3.2 Current Treatment for Spinal Muscular Atrophy 
3.3 Market Dynamics 
      3.3.1 Drivers 
      3.3.2 Restraints 
      3.3.3 Opportunities
3.3 Market Attractiveness Analysis

Chapter 4 : Pipeline Analysis: Spinal Muscular Atrophy 
4.1 Spinal Muscular Atrophy: Pipeline Overview 
4.2 Late Stage Candidates (Phase 3) 
      4.2.1 ISIS-SMN Rx 
4.3 Early Stage Candidates (Phase 1 and Phase 2) 
      4.3.1 Olesoxime (TRO19622)
      4.3.2 LMI070 
      4.3.3 RO6885247
      4.3.4 CK-2127107
      4.3.5 scAAV9.CB.SMN
      4.3.6 RG3039

Chapter 5 Recommendation 

Chapter 6 Company Profiles 
6.1 AveXis, Inc. 
6.2 Cytokinetics, Inc. 
6.3 F. Hoffmann-La Roche Ltd. 
6.4 Novartis AG 
6.5 Isis Pharmaceuticals, Inc.